This result suggests that in each transformed culture TP53-inactivating mutations had occurred during the first round of selection when cells were cultivated in the presence of ICR191, and that the progenitors of rare cells that had acquired TP53 gene mutations underwent clonal expansion during the second round of selection in tissue-culture conditions that simulated tumor environment. Here, TP53 is linked to neoplasm.